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Abstract. Phosphorylase activities (total and a form) were deter-
mined in the livers of experimental hepatic injuries with carbon tetra-
chloride or galactosamine and the livers of patients with liver diseases.
Experimental liver injuries caused a slight decrease in total activity in
later stages and a marked increase in a form activity in earlier stages.
In human livers, low values of total activity were found in acute hepati-
tis and cirrhosis of the liver with no consistent alteration in a activity.
Phosphorylase activities in hepatocellular carcinomas were also low.
The importance of the altered phosphory lase activities in hepatic injuries
is discussed in relation to the disorder in glycogen metabolism in the
injured liver.
Key words: CC14 liver injury, galactosamine liver injury, partial
hepatectomy, phosphorylase activity, glycogen metab-
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The level of glycogen in the liver is an important factor in determining the
susceptibility of parenchymal liver cells to hepatotoxins and other agents which
cause hepatic injuries. Decreased glycogen content in injured livers is also well
recognized. Accordingly, the elucidation of altered glycogen metabolism in the
injured liver is essential for both the prevention and treatment of liver diseases.
Although the glycogen phosphorylase (PLase; 1, 4-a:-D-glucan: orthophosphate
a-glucosyltransferase, EC 2. 4. 1. 1) has been well studied since the discovery of
interconversion of active (a) and inactive (b) forms of the enzyme through
phosphorylation and dephosphorylation reactions (1):. reports on phosphorylase
activities in injured livers are limited in number. Oeckerman (2) reported un-
altered PLase activity in cholelithiasis without referring to the a and b activities.
The discovery made by Appleman and others (3) that the b form is active in
the presence of both sulfate ion and AMP made it possible to estimate an ap-
proximate ratio of the active and inactive forms.
The present study was undertaken to determine the PLase activities in
injured livers of experimental animals and of hepatitis and cirrhosis patients.
PLase activities in partially hepatectomized rats were also studied to see the
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enzyme alteration in hepatic regeneration without injury and to compare the
results with those of hepatotoxin induced hepatic injuries, which also entail
hepatic regeneration following liver cell necrosis. Although no attempt was made
in this study to estimate the in vivo levels of active and inactive forms because of
some fundamental difficulties involved in the differential enzyme analysis (4),
several lines of evidence indicating an altered a and b interconversion in hepatic
injury were obtained in addition to the decrease in total PLase activity.
MATERIALS AND METHODS
Male Sprague-Dawley rats, maintained on Oriental Laboratory chow MF
and water ad libitum and weighing 135-180 g, were used throughout the experi-
ments. Acute carbon tetrachloride (CCI4 ) intoxication was produced by a single
administration of 0.5 ml of 20% CCl4 dissolved in olive oil per 100 g body weight
to 12 h fasted rats through a stomach tube intubated under light ether anesthesia.
Acute galactosamine intoxication was induced by a single intraperitoneal injection
of 150 mg of D-galactosamine hydrochloride (Gal-NH2), as a neutralized solution,
per 100 g body weight to similarly starved rats. The animals without those hepa-
totoxin treatments served as controls. Those three groups of rats were further
fasted for 24 h and given 5 g of the laboratory chow per 100 g body weight for
the second 24 h, 109 per 100g body weight for the third 24h and ad libitum for the
next four days. These dietary manipulations were made in order to minimize the
differences in dietary intake among the three groups of differently treated rats.
Partial hepatectomy was performed on well-fed rats according to the method of
Higgins and Anderson (5). Sham-operated rats served as controls to the hepatecto-
mized rats. These two groups of rats received the standard chow ad libitum
throughout the experimental period until sacrificed.
The animals were killed at indicated time intervals by decapitation and ex-
sanguination after an ether overdose. Livers were excised and homogenized in
four volumes of 63 mM Tris-HC1, pH 7.4, containing 25 mM 2-mercaptoethanol
and 6.3 mM EDTA, in a glass homogenizer with a Teflon pestle. Aliquots of the
homogenates were used for determination of glucose 6-phosphatase (G6Pase; EC
3.1. 3.9) activity by the method of Koide and Oda (6,7), and the remainders cen-
trifuged for 10 min at 5,000 x g. Aliquots of the supernatants were immediately
analyzed for total and a form PLase activities according to the procedure of Sato
and others (4). The remaining supernatants were centrifuged for 45 min at
105,000 x g for estimation of glucose 6-phosphate dehydrogenase (G6PD; EC 1. 1. 1.
49) activity with the resulting supernatants as described by Taketa et al. (8). The
protein concentrations of those tissue extracts were determined by the method
of Lowry and others (9). Alanine aminotransferase (GPT; EC 2.6. 1. 2) activities
in sera were determined colorimetrically (10). Glycogen contents in liver tissues
were assayed by a modified anthrone method (8). The procedures of tissue
extraction and centrifugation were carried out at 0-4°C. All the chemicals used
and described above were obtained from Sigma Chern. Co., St. Louis.
Biopsy specimens of human liver, amounting to 10-20 mg, obtained at perito-
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neoscopy or operation were processed similarly with a small scale homogenizer
and centrifuge tubes for analysis of PLase activities with the same system* as in
the assay of rat PLase (4). The enzyme activities were expressed as units per g
homogenate Or supernatant protein depending on the tissue extracts analyzed for
respective enzymes; one unit being defined as one ,umol of substrate reacted per
min at 37°C. All the results are given as means and standard errors of the means
for each group of animals.
RESULTS
Experimental liver injuries. Activities of liver PLase (total, a form and
a/total) in hepatotoxin treatments and partial hepatectomy are listed in Tables 1
and 2 together with several parameters of liver injury (serum CPT, liver C6PD
and C6Pase activities and liver glycogen content). Time course of PLase activ-
ities and glycogen content in livers of those experimental animals is illustrated in
Figs. 1,2 and 3.
In CC14-treated rats, total PLase activities decreased gradually, reaching a
minimum in 3 days and returned toward the initial value in 7 days. The control
activity also decreased for the first one day of starvation and recovered after
resuming dietary intake. Thus, a statistically significant decrease in activity was
found only in 3 days, when the activity of C6PD reached a peak and the activity
of C6Pase and the level of the glycogen were still low in the injured livers. In
contrast with the decrease in total PLase activity, the activity of a form and the
ratio of a to the total activity both increased markedly in the first 2 days of CC14
injury. Thus, the change in PLase a activity roughly paralleled that of serum
CPT elevation.
The results obtained with Cal-NH2-injured rats were quite similar to those
with CCl4-intoxicated animals in respect to the alteration in PLase activity,
although a rise in a form activity was noted in 7 days in association with a
marked increase in liver glycogen content. A retarded peak in the rise of serum
CPT activity and less marked decreases in liver C6Pase activity were also found
as compared with CCl4-treated rats.
In partially hepatectomized rats, the decreases in total PLase activity and
glycogen content in liver were slightly less than in CC14-treated rats, but the
differences from the sham-operated controls were larger. The increase in PLase
a activity was noted only when the activity was expressed relative to the total, as
similar increases in a form activity were also observed in the control livers. No
significant changes suggestive of hepatic injury wen!: observed in other parameters
following partial hepatectomy except for a decrease in liver C6Pase activity in
72 h.
* The incubation system was similar to that adopted for human PLase assay by Oeckerman
(2) except for the presence of sodium sulfate.
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TABLE 1. ACTIVITIES OF GPT IN SERA AND OF G6PD, G6PASE AND PLASE IN LIVERS AND CONTENT
OF GLYCOGEN IN LIVERS OF CCL4 AND GALACTOSAMINE-TREATED, AND CONTROL RATS
GPT Active tvTotal Active PLase/ Glycogen -...JConditions (Karmen G6PDn G6Pase (J, form of ~
units/ml) PLaseab nb Total (mg/g wet liver)PLase
CC14 24h(5)" 1740± 51 54.6± 7.0 20. 4±4. 2 107.7± 6.6 77. 6± 16. 6 O. 69±0. 13 O. 19±0. 02
48h (6) 820± 178 91.1±1O.7 31.4±3.5 76.2 ± 11. 4 70.0± 2.4- 0.91 ±O. 03 O. 26±0. 02
72h(6) HO±213 149. 3±23. 5 29. 2±4. 0 60.6± 4.6 9.7± 3.2 0.17±0.06 1. 1 ±0.2
1 w(3) 24± 4 60.3 ± 1. 8 41. 8±0. 5 145.9 ± 18. 5 17.1± 1.9 0.12±0.01 9.5 ±3.5
Galactosamine 24h(5) 82± 26 46.9± 5.9 62.2±3.0 99. 6± 18.4 124. 5±24. 8 1. 23±0. 04- 1. 7 ±0.4
48h(4) 1250±543 76.7± 2.3 50. 8±2. 3 108.6± 2.1 127.7± 2.1 1. 18±0. 03 1. 0 ±0.2
72h(5) 488±233 105. 4±19. 4 42.1 ±5. 4 72.7±11.1 13.8± 4.2 O. 24±0. 09 9.2 ±2.2
1 w(6) 27± 2 83.5± 5.8 45.1 ±3. 3 117.0± 0.2 76.5± 6.8 O. 68±0. 09 80.0±7.0
Control 24h(4) 20± 2 32.4± 1.6 79. 6±5. 6 90.3± 4.8 1O.4± 1. 2 O. l2±0. 02 5.9 ±0.19
48h(4) 16± 1 32.0± 2.4 60. 9±2. 5 99.2± 5.0 28.8±14.1 O. 29±0. 14 3.5 ± 1. 9
72h(5) 22± 2 47.6± 4.5 53. 6±3. 0 98.0± 3.7 14.4± 6.7 0.14±0.06 6.5 ±3.0
1 w(2) 30±- 7 74.4+ 6.0 55. 8±3. 6 138.8± 8.4 16.6± 2.9 O. 12±0. 01 23.0 ± 1. 0 ~
Well-fed control (4) 26± 1 42.2± 4.3 56. 2±2. 7 141. 1± 5.0 6.3± 0.5 0.05±0.002 46.0 ±4.0 ;;:::
-- -------- 0
a Units/g protein; b Total PLase activity was assayed in the presence of 0.5 M NaZS04 together with 1mM AMP. Activity of tT;l>
active form PLase was assayed in the absence of NazS04 and AMP. c Number in parenthesis, number of animals. ><:
>til
TABLE 2. ACTIVITIES OF GPT IN SERA AND OF G6PD, G6PASE AND PLASE IN LIVERS AND CONTENT :=
OF GLYCOGEN IN LIVERS OF HEPATECTOMIZED AND SHAM-OPERATED RATS
GPT Total Active Active PLase/ GlycogenCondition (Karmen G6PD(J, G6Pase n form of
units/m1) PLasenb Total (mg/g wet liver)PLasenb
Hepatectomized 24h(5)" l26±26 39.2± 4.4 52.2± 6.9 116. 5± 10. 2 111.3±11.9 1. 02±0. 17 12.6± 2.2
48h(5) 48± 6 53.8± 3.0 52.3± 8.6 106.9± 7.0 71.1±11.6 O. 66±0. 12 12.6± 3.4
72h(4) 50± 9 69.3± 4.2 28.8± 2.6 94.7 ± 2.9 63.0± 5.8 0.67 ±O. 07 l2.7± 2.7
1 w(3) 28± 3 71.1± 3.5 40.6± 4.5 96.6± 1. 7 24.0± 6.3 0.25±0.07 l5.4± 4.7
Sham-operated 24h(3) 27± 1 37.9± 1.2 59.3± 2.3 l20.9± 2.2 101. O± 12. 8 O. 34±0. 10 43. O± 10.0
48h(4) 36± 9 38.7± 2.6 54.6± 1. 9 181. 3± 5.3 43. 4± 11. 0 0.24±0.05 34.8± 6.9
72h(2) 27± 3 60. 8±13. 2 69.1±10.5 134.5±14.9 75.9± 0.3 O. 58±0. 06 29.5± 1.8
1 w(2) 30± 1 46.0± 5.5 59. 6± 14. 5 114.8±6.7 29.8± 1. 2 O. 26±0. 01 l4.2± 5.5
Well-fed control (4) 26± 1 42.2± 4.3 56.2± 2.7 141. 1± 5.0 6.3± 0.5 0.05±0.002 46.0± 4.0
a Units/g protein; b Total PLase activity was assayed in the presence of 0.5 M NazS04 together with 1 mM AMP. Activity of
active form PLase was assayed in the absence of NaZS04 and AMP. c number in parenthesis, number of animals.
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TABLE 3. PLASE ACTIVITY IN HUMAN LIVER DISEASES
Liver Serum
Case Diagnosis PLase activitya A' Total GOT
b GPT b Choline KICG~ --"----.-- ctlve bilirubin esterase
Total Actlve form/ (m /d1) (.6.pH)form Total g
Fatty liver 288.6 146.5 0.51 0.68 82 161 1. 23 0.15
2 Fatty liver 130. 7 91. 3 O. 70 1. 30 44 42 0.98 0.033
3 Acute hepatitis 90.3 47.5 0.53 1.11 28 43 O. 77 O. 15
4 Acute hepatitis 64.4 57.9 0.90 O. 71 41 141 0.92
5 Acute hepatitis 45.8 38.8 0.85 1. 19 31 40 0.82
6 Chronic persistent hepatitis 80. 7 25.0 0.31 0.94 22 66 0.92 O. 16
7 Chronic persistent hepatitis 106.5 34.4 0.32 O. 70 37 49 0.98 O. 19
8 Chronic persistent hepatitis 243. 7 157.5 0.65 0.42 31 38 0.98 0.18
9 Chronic persistent hepatitis 77.8 0 0 0.49 119 168 0.98 O. 14
10 Chronic aggressive hepa ti tis 173.4 123. 7 0.71 1.16 157 202 O. 78 O. 16
11 Chronic aggressive hepatitis 221. 0 114.7 0.52 O. 70 41 26 O. 75 O. 12
12 Chronic aggressive hepatitis 144.8 52.8 0.36 0.37 229 299 O. 73 O. 19
13 Chronic aggressive hepatitis 85.8 80.5 0.94 I. 41 94 76 0.68 O. 13
14 Liver cirrhosis 83.2 70. 1 0.84 0.92 88 129 0.59 0.11
15 Liver cirrhosis 57.4 28.0 0.49 0.47 46 35 O. 13
16 Liver cirrhosis 62.5 32.8 0.52 1.33 86 52 0.62
17 Liver cirrhosis 107. 7 7.8 0.07 1. 02 259 239 0.84 0.099
18 Liver cirrhosis 92.4 36.6 0.40 1. 52 70 66 0.63 0.11
19 Liver cirrhosis" 81. 1 4. 7 0.06 0.7I 90 91 0.59 0.11
20 Alcoholic liver injury 183.4 6.3 0.03 1. 42 163 150 0.63 0.076
21 Alcoholic liver injury 188.5 65.2 0.35 0.29 44 56 0.95 O. 12
22 Alcoholic liver cirrhosis 104. 1 20. 7 0.20 O. 72 72 87 O. 75
23 Alcoholic liver cirrhosis 114.6 0 0 1. 05 272 250 0.46 0.079
24 Primary biliary cirrhosis" 214.4 0 0 3.97 187 120 O. 70
25 Hepatoma", Tumor 82.2 71. 8 0.87 1. 97 136 76
Tumor-bearing liver 65.6 0.8 0.01
26 Hepatoma", Tumor 36.0 6.0 0.17 0.93 38 28 0.54
Tumor-bearing liver 140.0 5.0 0.04
---"-- ~-_.- -- -.,--~---
a Units/~ protein; b Karmen units/m1; c Livers obtained at operations, others at
pei toneoscopy.
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Human liver diseases. Liver PLase activities in various liver diseases are
shown in Table 3 together with results of some liver function tests. Although
the total PLase activity ranged widely, it tended to be lower in acute hepatitis
(convalescent), cirrhosis of the liver (postnecrotic) and hepatocellular carcinoma.
On the other hand, lower activities of a relative to the total were found in alco-
holic liver injuries. No consistent tendency was found between the changes in
PLase activities and the impairments in liver function tests.
DISCUSSION
In acute hepatic injuries produced by 0014 and Gal-NHz treatments, rela-
tively small decreases in total PLase activity were found in later stages of the
injuries as compared with the marked rises in PLase a activity with unaltered
total activity in earlier stages of the injuries. In the present system of preparing
tissue extracts, no sodium fluoride, an inhibitor of PLase phosphatase, was
included in the medium because of the reasons mentioned in the introduction.
Since the content of ATP in the liver supernatant is markedly reduced, the
increase in a form PLase may indicate the change in vivo, even though sodium
7
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fluoride was not added to the medium. The relative increase in the active form
in early phases of liver damage is most likely to be caused by an insufficiency
of PLase phosphatase activity. Another possibility of increased PLase kinase
activity is also plausible, provided that a sufficient amount of ATP remains in the
enzyme extracts. Under conditions in vivo, such a mechanism may be operating
in view of the fact that plasma glucagon and liver cyclic 3', 5'-adenosine mono-
phosphate concentrations are reported to be elevated in various hepatic injuries
(12, 13).
The increase in active form of PLase by liver injury would explain the
marked drop in glycogen content of injured liver as was observed in CClr or
Gal-NH2-intoxication, assuming that PLase a activity in vivo is elevated in injured
liver. No suitable explanation is available at present for the parallel rises of
PLase a and glycogen levels in 7 day rats after Gal- NH2 injection. The same
also applies to the discrepancy found in sham-operated controls; i. e. the in-
creased PLase a activity with minimum diminution in glycogen level. This
implies that the importance of the glycogen synthetase level in the injured liver,
although not fully understood, should be considered together with PLase.
A moderate decrease in total PLase activity and a relative increase in a form
activity found in regenerating livers after partial hepatectomy are somewhat
similar to those demonstrated with liver injuries. An enhanced regeneration of
hepatocytes usually follows the liver cell necrosis. Accordingly, the changes in
PLase activities caused by hepatic injuries could be ascribed to the mechanism
related to the regenerative process rather than the degenerative one, although the
contribution of the latter mechanism, namely hepatic damage per se, is also
evident, as it was revealed by further analysis of PLase isozyme patterns under
identical conditions (14). In most of the carbohydrate-metabolizing enzymes
examined, the changes induced by liver damage are generally much greater than
those produced by partial hepatectomy (15). This holds true for the enhanced
a-fetoprotein production by hepatic injury; this being much greater than that
caused by partial hepatectomy (16, 17).
The PLase activities in injured livers from patients varied widely even
within the same group of diseases. However, such a wide individual distribution
of PLase activity is reported in normal controls (2). The variation of PLase
activity in human liver is much greater than that of other enzyme activities of
carbohydrate metabolism (18). Therefore, it may not be due to simple technical
problems in analyzing the enzyme activity with small amounts of liver tissues.
Although the exact cause of the variation in PLase activity is not known, some
difference in dietary conditions of the individuals might be related. Reduced
dietary intake appears to result in decreased actitivity of total PLase as was
found in normal rats starved for one and a half days. In diseased human livers,
8
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the total PLase activity tended to decrease not only in primary hepatoma but also
in acute hepatitis or cirrhosis of the liver. This is in accord with the observation
made by analyses of other enzymes of carbohydrate metabolism; namely, paren-
chymalliver damage causes undifferentiated gene expression (15,18,19). No
consistent increase in a form activity was found even in cases with elevated
serum CPT activity, which was associated with increased a form activity in
experimental animals. The significance of lower PLase activities in alcoholic
liver injuries is not clear at present. The cases included in the present study had
relatively less severe hepatic damage because of the clinical indication for peri-
toneoscopy and biopsy. This may partly account for the minor change in PLase
activity of injured livers and also for the failure of obtaining significant correla-
tions between the change in PLase activity and the impairment in routine liver
function tests. The lower values of PLase activity obtained for hepatitis and cir-
rhosis of the liver are close to the levels reported for glycogen storage disease (2),
suggesting the physiological importance of the observed alteration in PLase
activity in acquired liver diseases in addition to the generally accepted disorders
in hormonal or dietary factors in terms of the dysregulation of carbohydrate
metabolism found in liver diseases.
Acknowledgment. The author wishes to express profound thanks to Professor Hideo
Nagashima for his instruction, to Dr. Kazuhisa Taketa for his guidance and helpful advice,
to Dr. Junnosuke Shimamura for his collabolation in animal experiments aud to Dr. Masahiro
Kubota and his group for their interest and support through liver biopsy under peritoneoscopy.
REFERENCES
1. Wosilait, W. D. and Sutherland, E. W.: The relationship of epinephrine and glucagon to
liver phosphorylase. II. Enzymatic inactivation of liver phosphorylase. ]. Biol. Chern.
218, 469-481, 1956.
2. Oeckerman, P. A.: A technique for the enzymatic diagnosis of glycogen storage disease
on very small tissue specimens. Acta Paediatr. Scand. 57, 105-109, 1968.
3. Appleman, M. M., Krebs, E. G. and Fischer, E. H.: Purification and properties of in-
active liver phosphorylase. Biochemistry 5, 2101-2107, 1966.
4. Sato, K., Satoh, K., Sato, T., Imai, F. and Morris, H. P.: Isozyme patterns of glycogen
phosphorylase in rat tissues and transplantable hepatomas. Cancer Res. 36, 487-495, 1976.
5. Higgins, G. M. and Anderson, R. M.: Experimental pathology of the liver: restration of
the liver of the white rat following partial surgical removal. Arch. Pathol. 12, 186-202,
1931.
6. Chen, P. S. Jr., Toribara, T. Y. and Warner, H.: Microdetermination of phosphorus. Anal.
Chem. 28, 1756-1758, 1956.
7. Koide, H. and Oda, T.: Pathological occurrence of glucose 6-phosphatase in serum in
liver diseases. Clin. Chern. Acta 4, 554-561, 1959.
8. Taketa, K., Kaneshige, Y., Tanaka, A. and Kosaka, K.: Differential responses of glucose
6-phosphate dehydrogenase and lipogenesis to fat free diets. Biochern. Med. 4, 531-545,
1970.
9. Lowry, O. H., Rosebrough, N. T., Farr, A. L. and Randall, R. J.: Protein measurement
9
Kobayashi: Studies of liver phosphorylase in hepatic injuries. I. Alteration
Produced by The Berkeley Electronic Press, 1978
282 M. KOBAYASH!
with the Folin phenol reagent. ]. Bioi. Chem. 193, 265-275, 1951.
10. Reitman, S. and Frankel, S.: A colorimetric method for the determination of serum
glutamic oxaloacetic and glutamic pyruvic transaminases. Am.]. Clin. Pathol. 28, 56-63,
1957.
11. Rall, T. W. and Sutherland, E. W.: Methods in Enzynology, ed. S. P. Colowick, and N. O.
Kaplan, Academic Press, New York, Vol. 5, pp. 384-391, 1962.
12. DeRubertis, F. R. and Craven, P.: Effects of reduced ATP content on hepatic responses
to glucagon. Metabolism 25, 57-67, 1976.
13. Jaspan, J. B., Huen, A. H-J., Morley, C. G., Moossa, A. R. and Rubenstein, A. H.: The
role of the liver in glucagen metabolism. ]. Clin. Invest. 60, 421-428, 1977.
14. Kobayashi, M.: Studies of liver phosphorylase in hepatic injury. II. Alteration in isozyme
pattern. Acta Med. Okayama lin press).
15. Taketa, K., Tanaka, A., Watanabe, A., Takesue, A., Aoe, H. and Kosaka, K.: Undiffer-
entiated patterns of key carbohydrate-metabolizing enzymes in injured livers. I. Acute
carbon-tetrachloride intoxication of ra t. Enzyme 21, 158-173, 1976.
16. Watanabe, A., Miyazaki, M. and Taketa, K.: Differential mechanisms of increased Q'-
fetoprotein production in rats following carbon tetrachloride injury and partial hepatec-
tomy. Cancer Res. 36, 2171-2175, 1976.
17. Taketa, K., Watanabe, A. and Kosaka, K.: Different mechanisms of increased rat Q'-
fetoprotein production in rats following CC14 intoxication and partial hepatectomy. Ann.
N. Y. Acad. Sci. 259, 80-84, 1975.
18. Taketa, K., Shimamura, j., Takesue, A., Tanaka, A. and Kosaka, K.: Undifferentiated
patterns of key carbohYdrate-metabolizing enzymes in injured livers. II. Human viral
hepatitis and cirrhosis of the liver. Enzyme 21, 200-210, 1976.
19. Taketa, K., Watanabe, A. and Kosaka, K.: Undifferentiated gene expression in liver
injuries. In Onco-Developmental Gene Expression, ed. W. H. Fishmen and S. Sell, Acad.
Press, New York, pp. 219-226, 1976.
10
Acta Medica Okayama, Vol. 32 [1978], Iss. 4, Art. 3
http://escholarship.lib.okayama-u.ac.jp/amo/vol32/iss4/3
